(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression ISO RGD:1553791 6480464 ethylene dichloride results in decreased expression of UGT2B1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of UGT2B17 mRNA CTD PMID:27840820 1-naphthaleneacetic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthaleneacetic acid CTD PMID:8302279 1-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthol CTD PMID:8302279 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of UGT2B1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of UGT2B1 protein CTD PMID:12663690 17alpha-ethynylestradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ethinyl Estradiol CTD PMID:15921999 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of UGT2B1 protein CTD PMID:12663690 17alpha-ethynylestradiol multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein], Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 17beta-estradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Estradiol CTD PMID:11836149 17beta-estradiol increases expression ISO RGD:1350006 6480464 Estradiol results in increased expression of UGT2B17 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1350006 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Dihydrotestosterone CTD PMID:8798464 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:10036216 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31826744 , PMID:32679240 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1553791 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1350006 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1350006 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA, Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553791 6480464 Tetrachlorodibenzodioxin affects the expression of UGT2B1 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of UGT2B1 mRNA CTD PMID:21346803 2-Ethylhexanoic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylhexanoic acid CTD PMID:8302279 2-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylphenol CTD PMID:8302279 2-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-naphthol CTD PMID:8302279 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of UGT2B17 mRNA CTD PMID:23052194 3-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-ethylphenol CTD PMID:8302279 3-phenylpropionic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-phenylpropionic acid CTD PMID:8302279 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of UGT2B1 mRNA CTD PMID:19162173 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases glucuronidation ISO RGD:1350006 6480464 UGT2B17 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 4-ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-ethylphenol CTD PMID:8302279 4-hydroxyphenyl retinamide increases expression ISO RGD:1553791 6480464 Fenretinide results in increased expression of UGT2B17 mRNA CTD PMID:28973697 4-methylumbelliferone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Hymecromone CTD PMID:8302279 4-methylumbelliferone increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Hymecromone CTD PMID:8798464 4-methylumbelliferone multiple interactions ISO RGD:1350006 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide, licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 , PMID:33290829 4-methylumbelliferone increases activity ISO RGD:1350006 6480464 Hymecromone results in increased activity of UGT2B17 protein CTD PMID:26875642 4-methylumbelliferone increases glucuronidation ISO RGD:1350006 6480464 UGT2B17 protein results in increased glucuronidation of Hymecromone CTD PMID:33290829 4-methylumbelliferone beta-D-glucuronide multiple interactions ISO RGD:1350006 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide CTD PMID:33290829 4-tert-butylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of butylphen CTD PMID:8302279 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of UGT2B1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of UGT2B1 mRNA CTD PMID:25825206 8-Br-cAMP increases expression ISO RGD:1350006 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA CTD PMID:22079614 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGT2B1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:23052194 , PMID:33354967 aflatoxin B1 increases expression ISO RGD:1350006 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:1350006 6480464 Aflatoxin B1 results in decreased methylation of UGT2B17 gene CTD PMID:27153756 aldrin increases expression ISO RGD:1553791 6480464 Aldrin results in increased expression of UGT2B1 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:1350006 6480464 Tretinoin results in decreased expression of UGT2B17 mRNA CTD PMID:23724009 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UGT2B1 mRNA CTD PMID:16940010 , PMID:17785943 amentoflavone decreases activity ISO RGD:1350006 6480464 amentoflavone results in decreased activity of UGT2B17 protein CTD PMID:29470958 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of UGT2B1 mRNA CTD PMID:18355885 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of UGT2B1 mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UGT2B1 mRNA CTD PMID:16483693 androstane-3,17-diol increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Androstane-3, 17-diol CTD PMID:8798464 androsterone increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Androsterone CTD PMID:8798464 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of UGT2B17 mRNA CTD PMID:23912714 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of UGT2B1 mRNA CTD PMID:18178546 Aroclor 1254 affects expression ISO RGD:1350006 6480464 Chlorodiphenyl (54% Chlorine) affects the expression of UGT2B17 mRNA CTD PMID:17851650 atrazine affects expression EXP 6480464 Atrazine affects the expression of UGT2B17 mRNA CTD PMID:22285353 benzene affects expression EXP 6480464 Benzene affects the expression of UGT2B1 mRNA CTD PMID:15878777 benzo[a]pyrene increases expression ISO RGD:1553791 6480464 Benzo(a)pyrene results in increased expression of UGT2B1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:1350006 6480464 Benzo(a)pyrene results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 benzyl alcohol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Benzyl Alcohol CTD PMID:8302279 bezafibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Bezafibrate CTD PMID:8302279 bicalutamide decreases expression ISO RGD:1350006 6480464 bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 biphenyl-4-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-phenylphenol CTD PMID:11836149 more ... bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1553791 6480464 Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1553791 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA] CTD PMID:19850644 bisphenol A increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of bisphenol A CTD PMID:10333482 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGT2B1 mRNA CTD PMID:29960846 bisphenol A increases expression ISO RGD:1553791 6480464 bisphenol A results in increased expression of UGT2B1 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGT2B1 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGT2B1 mRNA more ... CTD PMID:12230427 , PMID:25181051 buta-1,3-diene decreases expression ISO RGD:1553791 6480464 1, 3-butadiene results in decreased expression of UGT2B1 mRNA CTD PMID:29038090 butylated hydroxyanisole decreases expression ISO RGD:1553791 6480464 Butylated Hydroxyanisole results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 calcitriol decreases expression ISO RGD:1350006 6480464 Calcitriol results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1350006 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of UGT2B1 mRNA CTD PMID:17381134 carbon nanotube decreases expression ISO RGD:1553791 6480464 Nanotubes more ... CTD PMID:25620056 chloramphenicol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Chloramphenicol CTD PMID:8302279 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 ciprofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of ciprofibrate CTD PMID:8302279 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of UGT2B17 protein CTD PMID:22023808 clofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibrate CTD PMID:8302279 clofibrate decreases expression ISO RGD:1553791 6480464 Clofibrate results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 clofibrate multiple interactions ISO RGD:1553791 6480464 [Clofibrate co-treated with PPARA protein mutant form] results in increased expression of UGT2B1 mRNA CTD PMID:22496397 clofibric acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibric Acid CTD PMID:8302279 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA CTD PMID:17602206 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of UGT2B1 mRNA CTD PMID:10476907 cyclosporin A decreases expression ISO RGD:1553791 6480464 Cyclosporine results in decreased expression of UGT2B1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1350006 6480464 Cyclosporine results in decreased expression of UGT2B17 mRNA CTD PMID:27989131 cylindrospermopsin decreases expression ISO RGD:1350006 6480464 cylindrospermopsin results in decreased expression of UGT2B17 mRNA CTD PMID:30905859 cylindrospermopsin decreases expression ISO RGD:1553791 6480464 cylindrospermopsin results in decreased expression of UGT2B1 mRNA CTD PMID:20936652 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 daidzein increases expression ISO RGD:1350006 6480464 daidzein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 DDE multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of UGT2B1 mRNA CTD PMID:32679240 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UGT2B1 mRNA, Dexamethasone results in increased expression of UGT2B17 mRNA CTD PMID:11328961 more ... dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of UGT2B1 mRNA CTD PMID:15102944 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UGT2B1 mRNA CTD PMID:15901914 dichloroacetic acid decreases expression ISO RGD:1553791 6480464 Dichloroacetic Acid results in decreased expression of UGT2B1 mRNA CTD PMID:28962523 diclofenac increases glucuronidation ISO RGD:1350006 6480464 UGT2B17 protein results in increased glucuronidation of Diclofenac CTD PMID:15843492 , PMID:22265884 diethylstilbestrol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Diethylstilbestrol CTD PMID:11836149 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UGT2B1 mRNA CTD PMID:26335259 doxorubicin multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] CTD PMID:26335259 elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 endosulfan multiple interactions ISO RGD:1350006 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UGT2B1 mRNA CTD PMID:29391264 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of UGT2B17 mRNA CTD PMID:29391264 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 equol increases expression ISO RGD:1350006 6480464 Equol results in increased expression of UGT2B17 mRNA CTD PMID:16865672 ethyl methanesulfonate increases expression ISO RGD:1350006 6480464 Ethyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 eugenol increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Eugenol CTD PMID:8798464 felbamate increases expression EXP 6480464 felbamate results in increased expression of UGT2B1 mRNA CTD PMID:17381134 fipronil increases expression ISO RGD:1553791 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of UGT2B1 mRNA CTD PMID:16643972 flumequine decreases expression ISO RGD:1553791 6480464 flumequine results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 flumequine multiple interactions ISO RGD:1553791 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 flurbiprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Flurbiprofen CTD PMID:8302279 flutamide increases expression EXP 6480464 Flutamide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 formaldehyde increases expression ISO RGD:1350006 6480464 Formaldehyde results in increased expression of UGT2B17 mRNA CTD PMID:23649840 fumonisin B1 multiple interactions ISO RGD:1553791 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA, [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA CTD PMID:30448865 gabapentin increases expression EXP 6480464 gabapentin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 genistein multiple interactions ISO RGD:1553791 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:23333575 genistein increases expression ISO RGD:1350006 6480464 Genistein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of UGT2B1 mRNA CTD PMID:15345336 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of UGT2B1 mRNA CTD PMID:15159207 hydratropic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of hydratropic acid CTD PMID:8302279 ibuprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ibuprofen CTD PMID:8302279 imipramine affects expression EXP 6480464 Imipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of UGT2B1 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B17 mRNA CTD PMID:22129741 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of UGT2B1 mRNA CTD PMID:18355885 ketoprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ketoprofen CTD PMID:8302279 L-ascorbic acid multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Lasiocarpine increases expression EXP 6480464 lasiocarpine results in increased expression of UGT2B17 mRNA CTD PMID:32419051 Licochalcone A multiple interactions ISO RGD:1350006 6480464 licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 lipopolysaccharide decreases expression ISO RGD:1553791 6480464 Lipopolysaccharides results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of UGT2B17 mRNA CTD PMID:21311750 lorcaserin multiple interactions ISO RGD:1350006 6480464 UGT2B17 protein results in increased carbamoylation of and results in increased glucuronidation of lorcaserin CTD PMID:22259019 MeIQx multiple interactions ISO RGD:1553791 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 methyl methanesulfonate increases expression ISO RGD:1350006 6480464 Methyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of UGT2B1 mRNA CTD PMID:10036216 N-nitrosodiethylamine decreases expression ISO RGD:1553791 6480464 Diethylnitrosamine results in decreased expression of UGT2B1 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine multiple interactions ISO RGD:1553791 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UGT2B1 mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:1553791 6480464 Diethylnitrosamine results in increased expression of UGT2B1 mRNA CTD PMID:17942915 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of UGT2B1 mRNA CTD PMID:22037397 naproxen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Naproxen CTD PMID:8302279 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UGT2B17 mRNA CTD PMID:24136188 nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of UGT2B1 mRNA CTD PMID:16408618 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Nonylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of nonylphenol CTD PMID:11836149 O-methyleugenol decreases expression ISO RGD:1350006 6480464 methyleugenol results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 oltipraz decreases expression ISO RGD:1553791 6480464 oltipraz results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 oltipraz multiple interactions ISO RGD:1553791 6480464 [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of UGT2B1 mRNA CTD PMID:23665939 p-cresol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-cresol CTD PMID:8302279 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of UGT2B1 mRNA CTD PMID:27638505 pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UGT2B1 mRNA CTD PMID:30723492 paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 paracetamol multiple interactions ISO RGD:1553791 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:23333575 more ... paracetamol decreases expression ISO RGD:1553791 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:23333575 more ... paracetamol affects expression ISO RGD:1553791 6480464 Acetaminophen affects the expression of UGT2B1 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of UGT2B1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1553791 6480464 perfluorooctane sulfonic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:1553791 6480464 perfluorooctanoic acid results in decreased expression of UGT2B1 mRNA, perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA CTD PMID:17681415 , PMID:18467677 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of UGT2B17 mRNA CTD PMID:28511854 perfluorooctanoic acid affects expression ISO RGD:1553791 6480464 perfluorooctanoic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 perfluorooctanoic acid multiple interactions ISO RGD:1553791 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 phenformin increases expression EXP 6480464 Phenformin results in increased expression of UGT2B1 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA more ... CTD PMID:10036216 more ... phenobarbital increases expression ISO RGD:1553791 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA CTD PMID:19760798 phenobarbital decreases expression ISO RGD:1350006 6480464 Phenobarbital results in decreased expression of UGT2B17 mRNA CTD PMID:19084549 phenobarbital multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of UGT2B17 protein CTD PMID:8263600 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of UGT2B1 mRNA, Piperonyl Butoxide results in increased expression of UGT2B17 mRNA CTD PMID:17498859 more ... piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of UGT2B17 mRNA, Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of UGT2B17 mRNA] CTD PMID:18544911 , PMID:18648771 pirinixic acid multiple interactions ISO RGD:1553791 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 pirinixic acid decreases expression ISO RGD:1553791 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA, pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:18467677 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA, pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:19162173 , PMID:22484513 pirprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of pirprofen CTD PMID:8302279 poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of UGT2B1 mRNA CTD PMID:23939143 pravastatin decreases expression ISO RGD:1553791 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of UGT2B1 mRNA CTD PMID:19162173 , PMID:22037397 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of UGT2B1 mRNA CTD PMID:29038839 propiconazole increases expression ISO RGD:1553791 6480464 propiconazole results in increased expression of UGT2B1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of UGT2B1 mRNA, propiconazole results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... quercetin 3-O-beta-D-galactopyranoside multiple interactions ISO RGD:1553791 6480464 hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:26772156 quercetin 3-O-beta-D-galactopyranoside increases expression ISO RGD:1553791 6480464 hyperoside results in increased expression of UGT2B1 mRNA CTD PMID:26772156 quinolines increases expression EXP 6480464 Quinolines results in increased expression of UGT2B1 mRNA CTD PMID:9176741 rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 rotenone increases expression EXP 6480464 Rotenone results in increased expression of UGT2B1 mRNA CTD PMID:28374803 selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 senecionine decreases expression ISO RGD:1553791 6480464 senecionine results in decreased expression of UGT2B1 mRNA CTD PMID:31606820 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of UGT2B1 mRNA CTD PMID:8706011 taurine multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:26335259 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of UGT2B1 protein CTD PMID:24090815 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of UGT2B1 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:1553791 6480464 Testosterone results in increased expression of UGT2B1 mRNA CTD PMID:20844152 testosterone multiple interactions ISO RGD:1350006 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1350006 6480464 Testosterone results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1350006 6480464 Testosterone results in increased expression of UGT2B17 mRNA CTD PMID:21880219 testosterone increases metabolic processing ISO RGD:1350006 6480464 UGT2B17 protein results in increased metabolism of Testosterone CTD PMID:8798464 testosterone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Testosterone CTD PMID:11836149 , PMID:8302279 Testosterone propionate decreases expression EXP 6480464 Testosterone Propionate results in decreased expression of UGT2B1 mRNA CTD PMID:16829708 tetrachloromethane decreases expression ISO RGD:1553791 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 more ... tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UGT2B1 mRNA CTD PMID:32380060 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA, Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA CTD PMID:31150632 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of UGT2B1 mRNA, triadimefon results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... trichloroethene decreases expression ISO RGD:1553791 6480464 Trichloroethylene results in decreased expression of UGT2B1 mRNA CTD PMID:25549359 trifluralin increases expression EXP 6480464 Trifluralin results in increased expression of UGT2B1 mRNA CTD PMID:18582544 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of UGT2B1 mRNA CTD PMID:30589522 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 uranium atom multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein], Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 ursodeoxycholic acid increases glucuronidation ISO RGD:1350006 6480464 UGT2B17 protein results in increased glucuronidation of Ursodeoxycholic Acid CTD PMID:31299240 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of UGT2B17 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:1350006 6480464 Valproic Acid results in decreased expression of UGT2B17 mRNA CTD PMID:29154799 valproic acid decreases methylation ISO RGD:1350006 6480464 Valproic Acid results in decreased methylation of UGT2B17 gene CTD PMID:29154799 valproic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Valproic Acid CTD PMID:8302279 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UGT2B1 mRNA CTD PMID:17381134 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGT2B17 mRNA CTD PMID:22285353 vorinostat increases glucuronidation ISO RGD:1350006 6480464 UGT2B17 protein results in increased glucuronidation of vorinostat CTD PMID:25393417 vorinostat multiple interactions ISO RGD:1350006 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat, Warfarin inhibits the reaction [UGT2B17 protein results in increased glucuronidation of vorinostat] CTD PMID:25393417 warfarin multiple interactions ISO RGD:1350006 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat more ... CTD PMID:25393417 zaragozic acid A decreases expression ISO RGD:1553791 6480464 squalestatin 1 results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of UGT2B1 mRNA CTD PMID:27225895 zidovudine increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Zidovudine CTD PMID:8302279 zinc acetate multiple interactions EXP 6480464 [Taurine co-treated with Zinc Acetate] results in increased expression of UGT2B1 mRNA CTD PMID:26335259 zinc atom multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA], [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259 zinc(0) multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA], [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259
